ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
3,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
4,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,3,Vasodilation procedure,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
9,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
10,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
11,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
12,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
13,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
13,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
14,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
15,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
16,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
18,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
19,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
19,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
19,3,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
19,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
19,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,6,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
20,1,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,Y
21,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
23,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
23,2,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
24,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
24,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
26,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
27,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
27,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
28,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
29,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
31,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
32,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
33,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,2,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
34,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
35,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
37,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
38,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
39,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
40,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
41,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
41,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
41,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
41,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
42,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
42,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
43,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
43,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
44,1,Accidental poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
45,1,5'nucleotidase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
45,3,Anisochromia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
45,4,Anisocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
45,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
45,6,Bromosulphthalein test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
45,8,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,9,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
45,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
45,11,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
45,12,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
45,13,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
45,14,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
45,15,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
45,16,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
45,17,Liver palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
45,18,Liver scan abnormal,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
45,19,Neutrophil toxic granulation present,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
45,20,Occult blood positive,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
45,21,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
45,22,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
46,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
46,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
46,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
46,4,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
46,5,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
46,6,Headache,Headaches NEC,Headaches,Nerv,N
46,7,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
46,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
46,9,Marital problem,Family and partner issues,Family issues,SocCi,N
46,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
46,11,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
46,12,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
46,13,Paranoid personality disorder,Personality disorders with eccentric behaviour (Cluster A),Personality disorders and disturbances in behaviour,Psych,N
46,14,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
46,15,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
46,16,Suspiciousness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
47,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
47,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
47,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
47,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
48,1,Chemical burn of oral cavity,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
48,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
48,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
48,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
48,5,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
48,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
48,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
48,8,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
49,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
49,2,Bronchial disorder,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
49,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
49,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,7,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,8,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
49,10,Nocturnal dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
49,12,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
49,13,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,14,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,15,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,16,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,17,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,18,Respiratory tract inflammation,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
49,19,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
50,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
50,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
51,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
51,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
52,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
53,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
53,2,Exposure via direct contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
53,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
53,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
53,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
53,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
54,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
54,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
55,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
56,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
56,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
57,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
57,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
57,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
58,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
59,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
60,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
60,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
61,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
61,2,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
61,3,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
61,4,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
61,5,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
61,6,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
61,7,Application site pain,Application site reactions,Administration site reactions,Genrl,N
61,8,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
61,9,Application site rash,Application site reactions,Administration site reactions,Genrl,N
61,10,Application site scab,Application site reactions,Administration site reactions,Genrl,N
61,11,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
61,12,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
61,13,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
62,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
62,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
62,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
62,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
63,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
63,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
64,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
65,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
65,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
66,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
66,3,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
66,4,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
66,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
66,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
67,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
67,2,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
67,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
68,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
69,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
69,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
70,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
71,1,Administration site injury,Administration site reactions NEC,Administration site reactions,Genrl,N
71,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
71,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
71,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
72,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
73,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
73,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
74,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
74,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
75,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
75,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
75,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
75,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
76,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
76,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
76,3,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
77,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
77,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
77,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
77,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
77,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
77,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
77,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
77,8,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
77,9,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
78,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
78,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
79,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
79,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
79,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
80,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
81,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
81,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
81,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
81,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
82,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
83,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
84,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
84,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
84,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
85,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
86,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
86,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
86,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
88,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
88,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
89,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
90,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
91,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
92,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
92,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
92,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
92,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
92,6,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
92,7,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
92,8,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
92,9,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
92,10,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
92,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
93,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
93,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
94,1,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
94,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
94,3,Headache,Headaches NEC,Headaches,Nerv,N
94,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
94,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
95,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
95,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
96,1,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
96,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
97,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
98,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
99,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
100,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
101,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
101,2,Genital erythema,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
101,3,Genital tract inflammation,Reproductive tract infections and inflammations NEC,Reproductive tract disorders NEC,Repro,N
102,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
103,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
103,2,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
103,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
103,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
103,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
103,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
104,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
104,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
105,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
105,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
106,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
107,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
107,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
107,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
107,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
108,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
109,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
110,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
110,2,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
110,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
110,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
110,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
110,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
110,7,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
111,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
111,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
111,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
112,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
112,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
112,3,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
112,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
112,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
112,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
112,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
113,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
114,1,Hyposmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
114,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,3,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
114,4,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
115,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
115,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
115,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
115,5,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
116,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
116,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
117,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
117,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
117,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
117,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
117,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
118,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
118,2,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
118,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
118,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
118,5,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
118,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
119,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
119,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
120,2,Intentional product misuse to child,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
121,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
121,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
121,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
122,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
122,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
123,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
124,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
125,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
125,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
126,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
127,1,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
127,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
128,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
128,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
129,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
131,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
131,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
131,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
132,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
132,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
133,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
133,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
133,3,Exposure via eye contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
133,4,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
133,5,Eye abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
133,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
133,7,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
133,8,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
133,9,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
133,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
134,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
136,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
136,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
136,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
136,4,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
136,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
136,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
137,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
138,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
138,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
138,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
138,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
139,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
139,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
139,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
140,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
140,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
141,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
141,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
141,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
142,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
142,2,Headache,Headaches NEC,Headaches,Nerv,N
142,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
142,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
142,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
144,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
144,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
144,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
144,4,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
144,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
145,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
146,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
146,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
147,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
147,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
147,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
147,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
148,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
148,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
148,3,Intentional product misuse to child,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
149,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
150,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
151,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
152,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
153,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
153,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
154,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
154,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
154,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
154,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
154,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
155,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
156,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
156,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
157,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
157,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
157,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
157,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
158,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
158,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
158,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
158,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
159,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
159,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
159,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
160,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
160,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
161,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
162,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
162,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
162,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
162,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
162,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
163,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
163,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
164,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
164,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
165,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
166,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
166,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
167,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
167,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
167,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
167,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
168,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,2,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
168,3,Nasal mucosal blistering,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
169,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
170,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
171,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
171,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
171,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
172,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
172,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
172,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
172,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
173,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
174,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
175,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
175,2,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
175,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
175,4,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
175,5,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
175,6,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
175,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
